U-CSTL

Q:CSTL - CASTLE BIOSCIENCES INC - http://www.castelle.com/

21:06:59 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
CSTL - Q						22.23	-0.22	-1.0	88.5	1,881	1,540	22.70 22.70 22.04	47.27 15.58	16:01:39	Mar 18	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 1540

More trades...

Time ET	Ex	Price	Change	Volume
16:01:39	Q	22.23	-0.22	308
16:01:36	Q	22.23	-0.22	2
16:00:20	Q	22.23	-0.22	845
16:00:04	Q	22.23	-0.22	238
16:00:04	Q	22.23	-0.22	49
16:00:04	Q	22.23	-0.22	269
16:00:04	Q	22.23	-0.22	379
16:00:04	Q	22.23	-0.22	6
16:00:04	Q	22.23	-0.22	4
16:00:04	Q	22.23	-0.22	131

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-03-18 07:00	U:CSTL	News Release200	Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx ‚ ®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study
2023-03-14 07:00	U:CSTL	News Release200	Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
2023-03-10 07:00	U:CSTL	News Release200	Castle Biosciences to Highlight Clinical Value of Its Skin Cancer Tests at the 2023 American Academy of Dermatology (AAD) Annual Meeting
2023-03-08 07:00	U:CSTL	News Release200	Recommendations by Expert Consensus Panel Relating to Risk-Stratification Tests and Tools for Use in Cutaneous Melanoma Have Been Adopted as an Official Policy Recommendation of the National Society for Cutaneous Medicine

Date ET

Symbol

Type

Headline

2023-03-18 07:00

U:CSTL

News Release

Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx ‚ ®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study

2023-03-14 07:00

U:CSTL

News Release

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum